Covance

Covance is a global pharmaceutical company that specializes in research and development, drug discovery, biomedical engineering, healthcare, genomics, clinical trials, and dietary supplements . The company was founded on January 1, 1997, and is headquartered in Princeton, New Jersey . Covance is a public company listed on the New York Stock Exchange under the stock symbol CVD .

Covance has a strong global presence, with locations in the United States, Belgium, Brazil, Bulgaria, Czech Republic, China, Costa Rica, Germany, Hungary, India, Japan, Netherlands, Poland, Philippines, Russia, Romania, Spain, Switzerland, Slovakia, South Korea, Thailand, United Kingdom, Peru, Mexico, Australia, New Zealand, France, Israel, Turkey, South Africa, Argentina, Austria, and Ukraine . The company's main competitors include WuXi AppTec .

Andrew Schechter serves as the CEO of Covance, while Glenn Eisenberg is the company's CFO . Covance operates as a subsidiary of its parent organization, Covance Laboratories Limited .

The company's official website can be found at https://drugdevelopment.labcorp.com . Covance is also active on social media, with accounts on Twitter, LinkedIn, Facebook, and YouTube .

Covance has been assigned one patent and operates in various industries, including research, engineering, technology, biology, biotechnology, and regenerative medicine .